D-0823-2020 Class III Terminated

Recalled by Macleods Pharma Usa Inc — Plainsboro, NJ

FDA drug recall D-0823-2020 was initiated by Macleods Pharma Usa Inc on Jan 20, 2020 and is designated Class III. Reason for recall: Failed Dissolution Specifications: testing revealed low out of specification result in one lot of product The recall status is terminated (terminated Apr 26, 2021). Affected quantity: 10680 units.

Recall details

Product Type
Drugs
Report Date
Feb 5, 2020
Initiation Date
Jan 20, 2020
Termination Date
Apr 26, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10680 units

Product description

Montelukast Sodium Chewable Tablets, 5 mg, 90-count bottles, Rx Only, Manufactured for : Macleods Pharma USA, Inc. Plainsboro, NJ Manufactured by: Macleods Pharmaceuticals Ltd Baddi, Himachal Pradesh, India NDC 33342-111-10

Reason for recall

Failed Dissolution Specifications: testing revealed low out of specification result in one lot of product

Distribution pattern

Nationwide within the United States

Code information

Lot #: BMD8901B, Exp. Date 02/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0823-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0823-2020. Report a data issue: hello@regdatalab.com.